|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Structural protein
|
 |
|
Title:
|
 |
Solution structure of the sea domain of human mucin 1 (muc1)
|
|
Structure:
|
 |
Mucin-1. Chain: a. Fragment: sea domain (residues 1041-1097). Synonym: muc1 mucus protein, muc-1, polymorphic epithelial mucin, pem, pemt, episialin, tumor-associated mucin, carcinoma-associated mucin, tumor-associated epithelial membrane antigen, ema, h23ag, peanut- reactive urinary mucin, pum, breast carcinoma-associated antigen df3, cd227 antigen. Engineered: yes.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: muc1. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
NMR struc:
|
 |
15 models
|
 |
|
Authors:
|
 |
B.Macao,D.G.A.Johansson,G.C.Hansson,T.Hard
|
Key ref:
|
 |
B.Macao
et al.
(2006).
Autoproteolysis coupled to protein folding in the SEA domain of the membrane-bound MUC1 mucin.
Nat Struct Mol Biol,
13,
71-76.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
19-Jul-05
|
Release date:
|
17-Jan-06
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains A, B:
E.C.?
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Nat Struct Mol Biol
13:71-76
(2006)
|
|
PubMed id:
|
|
|
|
|
| |
|
Autoproteolysis coupled to protein folding in the SEA domain of the membrane-bound MUC1 mucin.
|
|
B.Macao,
D.G.Johansson,
G.C.Hansson,
T.Härd.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The single cell layer of the lungs and the gastrointestinal tract is protected
by the mucus formed by large glycoproteins called mucins. Transmembrane mucins
typically contain 110-residue SEA domains located next to the membrane. These
domains undergo post-translational cleavage between glycine and serine in a
characteristic GSVVV sequence, but the two peptides remain tightly associated.
We show that the SEA domain of the human MUC1 transmembrane mucin undergoes a
novel type of autoproteolysis, which is catalyzed by conformational stress and
the conserved serine hydroxyl. We propose that self-cleaving SEA domains have
evolved to dissociate as a result of mechanical rather than chemical stress at
the apical cell membrane and that this protects epithelial cells from rupture.
We further suggest that the cell can register mechanical shear at the mucosal
surface if the dissociation is signaled via loss of a SEA-binding protein.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. The human transmembrane mucins. Relative sizes of
the different domains in transmembrane mucins and the sites for
post-translational cleavage of the SEA (predicted for MUC16 and
MUC17) and vWD (only found in MUC4) domains are shown. The PTS
or mucin domains show considerable allelic variation in most of
these mucins, and the total number of amino acids therefore
varies. The MUC16 mucin is not fully N-terminally sequenced and
the known size is not shown to scale (truncated as marked). SEA
domains labeled "Cys pair" refer to sequences with two conserved
cysteines positioned to form a disulfide.
|
 |
Figure 3.
Figure 3. SEA domain sequences and the structure of human MUC1
SEA. (a) Alignment of human SEA domains in mucins
characterized by the GSVVV consensus sequence (dashed box) and
examples of uncleaved mucin SEA domains. Sequence numbering and
indicated secondary structure elements refer to the MUC1 SEA
fragment studied here. Color coding represents surface-exposed
side chains discussed in the text: magenta, Gly1097; blue,
Ser1098; orange, surface-exposed hydrophobic residues conserved
in mucin SEA domains; yellow, exposed hydrophobic residues
conserved across species in MUC1; red, side chains in acidic
region; cyan, asparagine residues subjected to N-linked
glycosylation in MUC1. The conserved cysteine pair in uncleaved
mucin SEA domains has been indicated by a line connecting boxed
cysteine residues; other cysteines are also boxed. Sequence
notation: h, human; m, mouse; SEA-1, SEA-2 and SEA-3, first,
second and third SEA domains in MUC16 counted from the membrane
domain toward the N terminus; rGP116, SEA domain in Ig-Hepta 7TM
(non-mucin) protein; 1IVZ_111000814|RIK, mouse MUC16 SEA homolog
with known structure^18. The alignment was made using
ClustalW28. (b) MUC1 SEA residues 1041-1144. The backbones of
cleavage-site Gly1097 and Ser1098 residues are shown as magenta
and blue sticks, respectively. Surface-exposed side chains
discussed in the text are colored as in a. (c) Backbone
superimposition of the ensemble of NMR structures. (d) Surface
representation of MUC1 SEA. The view at left is as in b and c
and the view at right is rotated by 180°. Color coding is as in
a and b. Surfaces were calculated for all heavy atoms of
residues 1041-1144 using a 1.4-Å probe. (e) The site for
autoproteolytic cleavage in MUC1 SEA. The view includes heavy
atoms and polar hydrogens of residues within 10 Å of the N' and
C' termini resulting from autoproteolysis of the peptide bond
between Gly1097 and Ser1098. Yellow, side chains of hydrophobic
residues; orange, conserved and surface-exposed Phe1054 and
Val1100 (as in a, b and d); dashed green lines, hydrogen bonds.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Macmillan Publishers Ltd:
Nat Struct Mol Biol
(2006,
13,
71-76)
copyright 2006.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.A.McGuckin,
S.K.Lindén,
P.Sutton,
and
T.H.Florin
(2011).
Mucin dynamics and enteric pathogens.
|
| |
Nat Rev Microbiol,
9,
265-278.
|
 |
|
|
|
|
 |
P.Mukhopadhyay,
S.Chakraborty,
M.P.Ponnusamy,
I.Lakshmanan,
M.Jain,
and
S.K.Batra
(2011).
Mucins in the pathogenesis of breast cancer: implications in diagnosis, prognosis and therapy.
|
| |
Biochim Biophys Acta,
1815,
224-240.
|
 |
|
|
|
|
 |
P.Premaratne,
K.Welén,
J.E.Damber,
G.C.Hansson,
and
M.Bäckström
(2011).
O-glycosylation of MUC1 mucin in prostate cancer and the effects of its expression on tumor growth in a prostate cancer xenograft model.
|
| |
Tumour Biol,
32,
203-213.
|
 |
|
|
|
|
 |
P.R.Hoorens,
M.Rinaldi,
R.W.Li,
B.Goddeeris,
E.Claerebout,
J.Vercruysse,
and
P.Geldhof
(2011).
Genome wide analysis of the bovine mucin genes and their gastrointestinal transcription profile.
|
| |
BMC Genomics,
12,
140.
|
 |
|
|
|
|
 |
R.Ahmad,
H.Rajabi,
M.Kosugi,
M.D.Joshi,
M.Alam,
B.Vasir,
T.Kawano,
S.Kharbanda,
and
D.Kufe
(2011).
MUC1-C oncoprotein promotes STAT3 activation in an autoinductive regulatory loop.
|
| |
Sci Signal,
4,
ra9.
|
 |
|
|
|
|
 |
B.Caffery,
M.L.Heynen,
E.Joyce,
L.Jones,
R.Ritter,
and
M.Senchyna
(2010).
MUC1 expression in Sjogren's syndrome, KCS, and control subjects.
|
| |
Mol Vis,
16,
1720-1727.
|
 |
|
|
|
|
 |
N.Khodarev,
R.Ahmad,
H.Rajabi,
S.Pitroda,
T.Kufe,
C.McClary,
M.D.Joshi,
D.MacDermed,
R.Weichselbaum,
and
D.Kufe
(2010).
Cooperativity of the MUC1 oncoprotein and STAT1 pathway in poor prognosis human breast cancer.
|
| |
Oncogene,
29,
920-929.
|
 |
|
|
|
|
 |
S.Altamura,
F.D'Alessio,
B.Selle,
and
M.U.Muckenthaler
(2010).
A novel TMPRSS6 mutation that prevents protease auto-activation causes IRIDA.
|
| |
Biochem J,
431,
363-371.
|
 |
|
|
|
|
 |
T.M.Antalis,
M.S.Buzza,
K.M.Hodge,
J.D.Hooper,
and
S.Netzel-Arnett
(2010).
The cutting edge: membrane-anchored serine protease activities in the pericellular microenvironment.
|
| |
Biochem J,
428,
325-346.
|
 |
|
|
|
|
 |
A.J.Ramsay,
J.D.Hooper,
A.R.Folgueras,
G.Velasco,
and
C.López-Otín
(2009).
Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasis.
|
| |
Haematologica,
94,
840-849.
|
 |
|
|
|
|
 |
A.J.Ramsay,
V.Quesada,
M.Sanchez,
C.Garabaya,
M.P.Sardà,
M.Baiget,
A.Remacha,
G.Velasco,
and
C.López-Otín
(2009).
Matriptase-2 mutations in iron-refractory iron deficiency anemia patients provide new insights into protease activation mechanisms.
|
| |
Hum Mol Genet,
18,
3673-3683.
|
 |
|
|
|
|
 |
D.B.Rubinstein,
M.Karmely,
E.Pichinuk,
R.Ziv,
I.Benhar,
N.Feng,
N.I.Smorodinsky,
and
D.H.Wreschner
(2009).
The MUC1 oncoprotein as a functional target: immunotoxin binding to alpha/beta junction mediates cell killing.
|
| |
Int J Cancer,
124,
46-54.
|
 |
|
|
|
|
 |
D.Raina,
R.Ahmad,
M.D.Joshi,
L.Yin,
Z.Wu,
T.Kawano,
B.Vasir,
D.Avigan,
S.Kharbanda,
and
D.Kufe
(2009).
Direct targeting of the mucin 1 oncoprotein blocks survival and tumorigenicity of human breast carcinoma cells.
|
| |
Cancer Res,
69,
5133-5141.
|
 |
|
|
|
|
 |
D.W.Kufe
(2009).
Mucins in cancer: function, prognosis and therapy.
|
| |
Nat Rev Cancer,
9,
874-885.
|
 |
|
|
|
|
 |
D.W.Kufe
(2009).
Functional targeting of the MUC1 oncogene in human cancers.
|
| |
Cancer Biol Ther,
8,
1197-1203.
|
 |
|
|
|
|
 |
G.Patsos,
and
A.Corfield
(2009).
Management of the human mucosal defensive barrier: evidence for glycan legislation.
|
| |
Biol Chem,
390,
581-590.
|
 |
|
|
|
|
 |
J.Julian,
N.Dharmaraj,
and
D.D.Carson
(2009).
MUC1 is a substrate for gamma-secretase.
|
| |
J Cell Biochem,
108,
802-815.
|
 |
|
|
|
|
 |
N.N.Khodarev,
S.P.Pitroda,
M.A.Beckett,
D.M.MacDermed,
L.Huang,
D.W.Kufe,
and
R.R.Weichselbaum
(2009).
MUC1-induced transcriptional programs associated with tumorigenesis predict outcome in breast and lung cancer.
|
| |
Cancer Res,
69,
2833-2837.
|
 |
|
|
|
|
 |
P.E.Mattila,
C.L.Kinlough,
J.R.Bruns,
O.A.Weisz,
and
R.P.Hughey
(2009).
MUC1 traverses apical recycling endosomes along the biosynthetic pathway in polarized MDCK cells.
|
| |
Biol Chem,
390,
551-556.
|
 |
|
|
|
|
 |
R.A.Cone
(2009).
Barrier properties of mucus.
|
| |
Adv Drug Deliv Rev,
61,
75-85.
|
 |
|
|
|
|
 |
S.K.Lindén,
Y.H.Sheng,
A.L.Every,
K.M.Miles,
E.C.Skoog,
T.H.Florin,
P.Sutton,
and
M.A.McGuckin
(2009).
MUC1 limits Helicobacter pylori infection both by steric hindrance and by acting as a releasable decoy.
|
| |
PLoS Pathog,
5,
e1000617.
|
 |
|
|
|
|
 |
W.R.Gordon,
M.Roy,
D.Vardar-Ulu,
M.Garfinkel,
M.R.Mansour,
J.C.Aster,
and
S.C.Blacklow
(2009).
Structure of the Notch1-negative regulatory region: implications for normal activation and pathogenic signaling in T-ALL.
|
| |
Blood,
113,
4381-4390.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Y.He,
Y.Li,
Z.Peng,
H.Yu,
X.Zhang,
L.Chen,
Q.Ji,
W.Chen,
and
R.Wang
(2009).
Role of N-glycosylation of the SEA module of rodent Muc3 in posttranslational processing of its carboxy-terminal domain.
|
| |
Glycobiology,
19,
1094-1102.
|
 |
|
|
|
|
 |
Z.Q.Huang,
and
D.J.Buchsbaum
(2009).
Monoclonal antibodies in the treatment of pancreatic cancer.
|
| |
Immunotherapy,
1,
223-229.
|
 |
|
|
|
|
 |
C.L.Hattrup,
and
S.J.Gendler
(2008).
Structure and function of the cell surface (tethered) mucins.
|
| |
Annu Rev Physiol,
70,
431-457.
|
 |
|
|
|
|
 |
M.E.Primo,
S.Klinke,
M.P.Sica,
F.A.Goldbaum,
J.Jakoncic,
E.Poskus,
and
M.R.Ermácora
(2008).
Structure of the mature ectodomain of the human receptor-type protein-tyrosine phosphatase IA-2.
|
| |
J Biol Chem,
283,
4674-4681.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.L.Oppizzi,
A.Akhavan,
M.Singh,
J.E.Fata,
and
J.L.Muschler
(2008).
Nuclear translocation of beta-dystroglycan reveals a distinctive trafficking pattern of autoproteolyzed mucins.
|
| |
Traffic,
9,
2063-2072.
|
 |
|
|
|
|
 |
N.Agata,
R.Ahmad,
T.Kawano,
D.Raina,
S.Kharbanda,
and
D.Kufe
(2008).
MUC1 oncoprotein blocks death receptor-mediated apoptosis by inhibiting recruitment of caspase-8.
|
| |
Cancer Res,
68,
6136-6144.
|
 |
|
|
|
|
 |
R.J.Strawbridge,
M.Nistér,
K.Brismar,
H.Grönberg,
and
C.Li
(2008).
MUC1 as a Putative Prognostic Marker for Prostate Cancer.
|
| |
Biomark Insights,
3,
303-315.
|
 |
|
|
|
|
 |
S.Mahanta,
S.P.Fessler,
J.Park,
and
C.Bamdad
(2008).
A minimal fragment of MUC1 mediates growth of cancer cells.
|
| |
PLoS ONE,
3,
e2054.
|
 |
|
|
|
|
 |
Y.Li,
Z.Peng,
Y.He,
W.Chen,
X.Bian,
D.Fang,
and
R.Wang
(2008).
Contribution of the conservative cleavage motif to posttranslational processing of the carboxyl terminal domain of rodent Muc3.
|
| |
Mol Cell Biochem,
313,
155-166.
|
 |
|
|
|
|
 |
J.Carey,
S.Lindman,
M.Bauer,
and
S.Linse
(2007).
Protein reconstitution and three-dimensional domain swapping: benefits and constraints of covalency.
|
| |
Protein Sci,
16,
2317-2333.
|
 |
|
|
|
|
 |
J.M.Kneller,
T.Ehlen,
J.P.Matisic,
D.Miller,
D.Van Niekerk,
W.L.Lam,
M.Marra,
R.Richards-Kortum,
M.Follen,
C.Macaulay,
and
S.J.Jones
(2007).
Using LongSAGE to Detect Biomarkers of Cervical Cancer Potentially Amenable to Optical Contrast Agent Labelling.
|
| |
Biomark Insights,
2,
447-461.
|
 |
|
|
|
|
 |
L.Yin,
S.Kharbanda,
and
D.Kufe
(2007).
Mucin 1 oncoprotein blocks hypoxia-inducible factor 1alpha activation in a survival response to hypoxia.
|
| |
J Biol Chem,
282,
257-266.
|
 |
|
|
|
|
 |
S.Ramasamy,
S.Duraisamy,
S.Barbashov,
T.Kawano,
S.Kharbanda,
and
D.Kufe
(2007).
The MUC1 and galectin-3 oncoproteins function in a microRNA-dependent regulatory loop.
|
| |
Mol Cell,
27,
992.
|
 |
|
|
|
|
 |
T.Lang,
G.C.Hansson,
and
T.Samuelsson
(2007).
Gel-forming mucins appeared early in metazoan evolution.
|
| |
Proc Natl Acad Sci U S A,
104,
16209-16214.
|
 |
|
|
|
|
 |
W.R.Gordon,
D.Vardar-Ulu,
G.Histen,
C.Sanchez-Irizarry,
J.C.Aster,
and
S.C.Blacklow
(2007).
Structural basis for autoinhibition of Notch.
|
| |
Nat Struct Mol Biol,
14,
295-300.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Y.Leng,
C.Cao,
J.Ren,
L.Huang,
D.Chen,
M.Ito,
and
D.Kufe
(2007).
Nuclear import of the MUC1-C oncoprotein is mediated by nucleoporin Nup62.
|
| |
J Biol Chem,
282,
19321-19330.
|
 |
|
|
|
|
 |
C.L.Kinlough,
R.J.McMahan,
P.A.Poland,
J.B.Bruns,
K.L.Harkleroad,
R.J.Stremple,
O.B.Kashlan,
K.M.Weixel,
O.A.Weisz,
and
R.P.Hughey
(2006).
Recycling of MUC1 is dependent on its palmitoylation.
|
| |
J Biol Chem,
281,
12112-12122.
|
 |
|
|
|
|
 |
M.E.Charbonneau,
F.Berthiaume,
and
M.Mourez
(2006).
Proteolytic processing is not essential for multiple functions of the Escherichia coli autotransporter adhesin involved in diffuse adherence (AIDA-I).
|
| |
J Bacteriol,
188,
8504-8512.
|
 |
|
|
|
|
 |
T.Lang,
G.C.Hansson,
and
T.Samuelsson
(2006).
An inventory of mucin genes in the chicken genome shows that the mucin domain of Muc13 is encoded by multiple exons and that ovomucin is part of a locus of related gel-forming mucins.
|
| |
BMC Genomics,
7,
197.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |